AzTrials
AzTrials

Environmental ExposurePhase 2/3INPOLNCT07465315

Behavioural Intervention to Decrease Exposure to Emerging Chemical Pollutants

A Phase 2/3 study testing Guidelines from the public healthcare system and INPOL healthy lifestyle informative guidelines in people with Environmental Exposure, run by Universidad de Granada at 5 sites in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of a behavioural intervention designed to reduce exposure to environmental chemical pollutants among adults in Spain. Read more about this study

Who is it for?
Ages 30 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Environmental Exposure
What is being tested?
Guidelines from the public healthcare system and INPOL healthy lifestyle informative guidelines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
740 participants
Where
5 sitesSpain
Study dates
May 2026to Feb 2027
Phase
Phase 2/3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Not planning to change residence within one year after recruitment
  • Spanish fluency
  • Living independently in the community
  • WhatsApp user
  • Age 30-60 years
  • Providing signed informed consent
Show all 13Show fewer
  • Not planning to change residence within one year after recruitment
  • Spanish fluency
  • Living independently in the community
  • WhatsApp user
  • Age 30-60 years
  • Providing signed informed consent
  • Participant of the Screening phase

Who cannot join

  • Unable to provide any of the required biological samples
  • Suffering any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses
  • Inability to understand the informed consent, questionnaires, or intervention
  • Already participating in another intervention trial at the time of recruitment
  • Pregnancy or lactation
  • Inability to communicate with the research team and/or to attend the follow-up visits
Show all 12Show fewer
  • Unable to provide any of the required biological samples
  • Suffering from any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses
  • Inability to understand the informed consent, questionnaires, or intervention
  • Already participating in another intervention trial at the time of recruitment
  • Pregnancy or lactation
  • Inability to communicate with the research team and/or attend follow-up visits

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

Spain5 sites
  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Madrid, 28942

    Juan P Arrebola, +34 ext. 958 24 96 18, jparrebola@ugr.es

  • Hospital Universitario Clínico San Cecilio

    Granada, Granada, 18007

    Juan P Arrebola, 958 24 9618 ext. +34, jparrebola@ugr.es

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, 28041

    Juan P Arrebola, 958 24 96 18 ext. +34, jparrebola@ugr.es

  • Clínica de neurociencias Imbrain

    Melilla, Melilla, 52001

    Juan P Arrebola, 958 24 96 18 ext. +34, jparrebola@ugr.es

  • Hospital Comarcal Santa Ana

    Motril, Granada, 18600

    Juan P Arrebola, 958 24 96 18 ext. +34, jparrebola@ugr.es

Other trials in Spain

About this study

Official title: Effectiveness of a Behavioural Intervention to Decrease Exposure to Emerging Chemical Pollutants Compared to Standard Lifestyle Recommendations Among Adults in Spain (INPOL): a 3-month Multicentre, Parallel-group, Superiority Randomized Controlled Trial

The purpose of this study is to evaluate the effectiveness of a behavioural intervention designed to reduce exposure to environmental chemical pollutants among adults in Spain.

Being tested
Guidelines from the public healthcare system, INPOL healthy lifestyle informative guidelines
Keywords
Environmental Exposure, Biological Monitoring, Biomarkers, Urine, Hair, Environmental Pollutants, Healthy Lifestyle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guidelines from the public healthcare systemBehavioural

    Healthy lifestyle guidelines from the public healthcare system, supported by short talks

  • INPOL healthy lifestyle informative guidelinesBehavioural

    Informative guidelines focused on how to decrease environmental chemical pollutant exposure, supported by short talks and social network interaction.

Study groups in NCT07465315
Study groupRoleWhat they receive
Current recommendationsActive comparatorParticipants will receive healthy lifestyle guidelines from the public healthcare system, supported by short talks
Receives: Behavioral: Guidelines from the public healthcare system
INPOL recommendationsExperimentalParticipants will receive informative guidelines focused on how to decrease environmental chemical pollutant exposure, supported by short talks and social network interaction
Receives: Behavioral: INPOL healthy lifestyle informative guidelines

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference between groups in the average number of measured pollutants that decrease by at least 5% from baseline to the 3 month follow up

    Measured: From baseline to 3 month follow-up

Secondary outcomes (2)
  1. Difference between groups in the average number of measured chemicals that increase by at least 5% from baseline to 3 month follow-up between groups

    Measured: Baseline to 3 month follow-up

  2. Difference between groups in the average individual chemical concentrations at 3-month follow-up

    Measured: Baseline to 3 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2026
  2. Study startMay 2026 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
740 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07465315
Sponsor's protocol ID
PI23/01799
Acronym
INPOL
Status last verified
Mar 2026
First submitted
6 Mar 2026
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Guidelines from the public healthcare system and INPOL healthy lifestyle informative guidelines in people with Environmental Exposure, run by Universidad de Granada at 5 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Juan P Arrebola (958 24 96 18 ext. 34, jparrebola@ugr.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference between groups in the average number of measured pollutants that decrease by at least 5% from baseline to the 3 month follow up (time frame: From baseline to 3 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in